Prophylactic Neulasta® Reduces Febrile Neutropenia and Early Deaths Among...
Prophylactic use of Neulasta® (pegfilgrastim) among cancer patients receiving chemotherapy reduces the risk of developing febrile neutropenia and early death. These results were recently published in...
View ArticleEarly Use of Neulasta® Superior to Later Use In Elderly Patients Undergoing...
The use of Neulasta® (pegfilgrastim) after the first cycle of chemotherapy among elderly patients undergoing chemotherapy decreases febrile neutropenia and associated effects compared with its use...
View ArticleNeulasta® Deemed Cost-effective for Prevention of Febrile Neutropenia in...
The prophylactic use of Neulasta® (pegfilgrastim) is cost-effective for the prevention of febrile neutropenia in patients undergoing treatment for breast cancer. The details of this study appeared in...
View ArticleDose Intensity Associated with Survival in Non-Hodgkin’s Lymphoma
Relative dose intensity (RDI) remains a key factor in the outcomes of patients with non-Hodgkins lymphoma (NHL). These results have been validated in several multicenter clinical studies. Non-Hodgkin’s...
View ArticleSuccessful Treatment Means Staying on Schedule
In order to receive the best possible benefit from your cancer therapy, it is important to follow your treatment as your doctor has prescribed. Even if you’re not able to visit your regular treatment...
View ArticleConquering Chemotherapy-How advances in the management of neutropenia have...
By Maria G. Essig, MS, ELS If you were to ask the average person—even the most health conscious of your friends—what their neutrophil count is, chances are you would get a blank stare. But as a cancer...
View ArticlePatient Action to Prevent Infection During Treatment for Cancer
Most patients would prefer to prevent infection rather than having to deal with its results. Your first line of defense should always be prevention. Below are some simple but effective steps to avoid...
View ArticleIt’s Not Just a Little Fever: Preventing Infection during Therapy for Lymphoma
Many cancer patients are at an increased risk of infection because of their low levels of infection-fighting white blood cells, a condition called neutropenia. The most common reason that cancer...
View ArticleChemotherapy for Older Patients: What You Should Know About the Risk of...
As you may already know, chemotherapy works by attacking the rapidly dividing cells it finds in the body, particularly cancer cells because they multiply quickly. However, chemotherapy can’t...
View ArticleNaproxen May Relieve Bone Pain Associated with Neulasta
Twice-daily naproxen is effective in reducing the incidence and severity of bone pain associated with the use of Neulasta® (pegfilgrastim), according to the results of a study published in the Journal...
View Article
